CoChat

The Effect of Dehydroepiandrosterone Supplementation to Symptomatic Perimenopausal Women on Serum Endocrine Profiles, Lipid Parameters, and Health-Related Quality of Life

Barnhart, Kurt T., Freeman, Ellen, Grisso, Jeanne Anne, Rader, Daniel J., Sammel, Mary, Kapoor, Shiv, Nestler, John E. · 2000 · Obstetrical & Gynecological Survey
Cited by 62

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Circulating levels of dehydroepiandrosterone (DHEA), an androgen primarily of adrenal gland origin, decline with advancing age so that perimenopausal women have only about half of peak levels. Although scientific data are limited, DHEA has been increasingly used as a dietary supplement to combat symptoms of aging and to enhance general well-being. This is the first randomized, double-blind, placebo-controlled study of oral DHEA supplementation. Sixty perimenopausal women aged 45 to 55 years who reported symptoms of fatigue, anxiety, irritability, depression, insomnia, difficulty remembering or concentrating, or decreased libido and who had been amenorrheic for at least 2 months in the past year but not for longer than 12 months formed the study population. They were assigned to receive 50 mg of DHEA daily in capsule form or a placebo capsule for 3 months. The treatment and placebo groups were comparable at baseline. Serum testosterone as well as DHEA levels rose significantly in the treated group, and cortisol levels declined significantly compared with the placebo group. High-density lipoprotein levels fell 10 percent from baseline in women assigned to receive DHEA and 3 percent in placebo recipients. Lipoprotein(a) levels decreased 18 and 8 percent, respectively. There were no significant changes in total cholesterol, triglycerides, low-density lipoprotein, or apolipoprotein levels. Scores for change in the severity of perimenopausal symptoms did not differ significantly in the treatment and control groups after 3 months. Overall, there was a significant reduction in total symptom scores and improvement in quality-of-life scores. These findings suggest that DHEA supplementation would best be used under medical supervision and that endocrine and lipid parameters should be monitored in recipients. There is no support for replacing estrogen by DHEA when treating perimenopausal or postmenopausal symptoms. There is insufficient evidence to warrant prescribing DHEA to improve well-being and quality of life. J Clin Endocrinol Metab 1999;84:3896–3902

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00006254-200004000-00020

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 62

Metadata

Authors
Barnhart, K. T., Freeman, E., Grisso, J. A., Rader, D. J., Sammel, M., Kapoor, S., & Nestler, J. E.
Venue
Obstetrical & Gynecological Survey
Published
2000-04
Volume
55
Issue
4
Pages
225-226
ISSN
0029-7828 (ISSN-L)
OpenAlex
W1965260099
Cited by
62
References
7
FWCI
1.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effect of Dehydroepiandrosterone Supplementation to Symptomatic Perimenopausal Women on Serum Endocrine Profiles, Lipid Parameters, and Health-Related Quality of Life. https://app.cochat.ai/papers/10.1097/00006254-200004000-00020
The paper
Barnhart, K. T., Freeman, E., Grisso, J. A., Rader, D. J., Sammel, M., Kapoor, S., & Nestler, J. E. (2000). The Effect of Dehydroepiandrosterone Supplementation to Symptomatic Perimenopausal Women on Serum Endocrine Profiles, Lipid Parameters, and Health-Related Quality of Life. Obstetrical & Gynecological Survey. https://doi.org/10.1097/00006254-200004000-00020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.